Literature DB >> 31950328

The Simplified Chinese version of SF-6Dv2: translation, cross-cultural adaptation and preliminary psychometric testing.

Jing Wu1, Shitong Xie2, Xiaoning He2, Gang Chen3, John E Brazier4.   

Abstract

PURPOSE: To translate, cross-culturally adapt and preliminarily test the Simplified Chinese version of SF-6Dv2 among the Chinese general population.
METHODS: The translation followed the international guidelines. Face-to-face cognitive debriefing was carried out in a small sample of the Chinese general population, using both think-aloud and retrospective probing methods. Preliminary psychometric properties (including acceptability, ceiling/floor effect and known-group validity) were investigated using a cross-sectional survey which was conducted in a representative sample of the general population in Tianjin, China.
RESULTS: Translation was conducted by forward- and back-translation, followed by harmonization and expert review. Two minor modifications were made during cognitive debriefing. Five hundred and nine respondents (54.4% males, aged 18-86 years) participated in the psychometric testing survey. The mean (standard deviation) duration of finishing SF-6Dv2 was 96.9 s (58.5 s). No respondents claimed difficulties on understanding/answering, and no ceiling/floor effect was found in the total summary score. Known-group validity verified that the questionnaire was able to distinguish between subgroups in terms of whether having chronic conditions.
CONCLUSIONS: The Simplified Chinese version of SF-6Dv2 is demonstrated to be conceptually equivalent with the original English version, which is also understandable and easy to finish among the Chinese general population.

Keywords:  China; Cross-cultural adaption; Health-related quality of life; Psychometric test; SF-6D; Translation

Year:  2020        PMID: 31950328     DOI: 10.1007/s11136-020-02419-3

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  5 in total

1.  Population Norms for SF-6Dv2 and EQ-5D-5L in China.

Authors:  Shitong Xie; Jing Wu; Feng Xie
Journal:  Appl Health Econ Health Policy       Date:  2022-02-08       Impact factor: 3.686

2.  Valuation of SF-6Dv2 Health States in China Using Time Trade-off and Discrete-Choice Experiment with a Duration Dimension.

Authors:  Jing Wu; Shitong Xie; Xiaoning He; Gang Chen; Gengliang Bai; Da Feng; Ming Hu; Jie Jiang; Xiaohui Wang; Hongyan Wu; Qunhong Wu; John E Brazier
Journal:  Pharmacoeconomics       Date:  2021-02-18       Impact factor: 4.981

3.  A methodological study on the combination of qualitative and quantitative methods in cognitive interviewing for cross-cultural adaptation.

Authors:  Miao Jia; Yao Gu; Yanhua Chen; Jinyi Tu; Yue Liu; Huiqi Lu; Simin Huang; Jinjun Li; Hongzhen Zhou
Journal:  Nurs Open       Date:  2021-10-30

4.  China Health Related Outcomes Measures (CHROME): Development of a New Generic Preference-Based Measure for the Chinese Population.

Authors:  Jing Wu; Xiaoning He; Pinan Chen; Shitong Xie; Xue Li; Hao Hu; Kun Zhao; Feng Xie
Journal:  Pharmacoeconomics       Date:  2022-07-18       Impact factor: 4.558

5.  Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey.

Authors:  Shitong Xie; Dingyao Wang; Jing Wu; Chunyu Liu; Wenchen Jiang
Journal:  Health Qual Life Outcomes       Date:  2022-06-16       Impact factor: 3.077

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.